Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

MNKD Insider Trading

MANNKIND CORP | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at MANNKIND CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-02-01 02:19 2019-01-31 Binder Steven B. Officer - Chief Financial Officer BUY $1.07 1,860 $1,990 3,620 +105.7%
2019-02-01 02:03 2019-01-31 Castagna Michael Director, Officer - Chief Executive Officer BUY $1.07 5,000 $5,350 98,157 +5.4%
2019-02-01 02:15 2019-01-31 Tross Stuart A Officer - Corp VP, Chief People Officer BUY $1.07 5,000 $5,350 80,040 +6.7%
2018-08-07 02:17 2018-08-02 Barton Courtney Officer - Chief Compliance Officer BUY $1.31 5,000 $6,550 7,000 +250.0%
2018-08-07 02:19 2018-08-02 McCauley Patrick Officer - Chief Commercial Officer BUY $1.31 5,000 $6,550 31,041 +19.2%
2018-08-07 02:17 2018-08-02 Binder Steven B. Officer - Chief Financial Officer BUY $1.31 1,760 $2,306 1,760 +100.0%
2018-08-07 02:16 2018-08-02 Castagna Michael Director, Officer - Chief Executive Officer BUY $1.31 5,000 $6,550 68,157 +7.9%
2018-08-07 02:21 2018-08-02 Tross Stuart A Officer - Corp VP, Chief People Officer BUY $1.31 5,000 $6,550 62,960 +8.6%
2017-12-22 05:36 2017-12-21 Tross Stuart A Officer - Corp VP, Chief People Officer BUY $2.52 39,840 $100,397 59,840 +199.2%
2017-12-21 00:53 2017-12-20 Castagna Michael Director, Officer - Chief Executive Officer BUY $2.29 8,000 $18,291 1,500 +100.0%
2017-10-14 00:03 2017-10-13 KRESA KENT Director BUY $6.00 166,600 $999,600 237,589 +234.7%
2017-08-24 02:10 2017-06-30 Alinaya Rosabel Realica Officer - SVP, Investor Relations BUY $1.23 2,000 $2,460 30,091 +7.1%
2017-08-24 02:07 2017-06-30 PFEFFER MATTHEW J Director BUY $1.23 2,000 $2,460 82,617 +2.5%
2017-08-12 01:17 2017-08-10 Urbanski Raymond W. Officer - Corp VP, CMO SELL $1.15 296 $340 2,924 -9.2%
2017-01-04 21:20 2017-01-03 Alinaya Rosabel Realica Officer - SVP, Prin Acctg Officer BUY $0.54 9,043 $4,883 140,456 +6.9%
2017-01-04 21:21 2017-01-03 PFEFFER MATTHEW J Officer - CEO, CFO, Director BUY $0.54 4,540 $2,452 403,085 +1.1%
2016-08-29 15:53 2016-08-26 Castagna Michael Officer - Chief Commercial Officer BUY $0.78 17,500 $13,650 212,500 +9.0%
2016-08-25 01:43 2016-08-24 Castagna Michael Officer - Chief Commercial Officer BUY $0.87 15,000 $13,050 195,000 +8.3%
2016-08-24 15:41 2016-08-23 Castagna Michael Officer - Chief Commercial Officer BUY $0.94 25,000 $23,468 180,000 +16.1%
2016-08-16 14:56 2016-08-12 Castagna Michael Officer - Chief Commercial Officer BUY $1.00 25,000 $24,888 75,000 +50.0%
2016-08-16 14:54 2016-08-15 PFEFFER MATTHEW J Officer - CEO, CFO, Director BUY $0.99 25,000 $24,650 397,996 +6.7%
2016-07-19 01:30 2016-07-06 Alinaya Rosabel Realica Officer - SVP, Prin Acctg Officer SELL $1.06 6,294 $6,672 131,413 -4.6%
2016-05-18 15:00 2016-05-17 Castagna Michael Officer - Chief Commercial Officer BUY $0.93 50,000 $46,500 50,000 +100.0%
2015-05-27 01:02 2015-05-21 Martens Juergen Officer - Corporate VP and COO BUY $4.57 20,000 $91,400 88,776 +29.1%
2015-04-25 04:25 2015-04-24 Edstrom Hakan Director, Officer - President & CEO OPT+S $4.83 73,460 $354,768 1,060,302 0.0%
2015-04-01 02:41 2015-03-27 Edstrom Hakan Director, Officer - President & CEO OPT+S $5.21 73,460 $382,829 1,058,824 0.0%
2015-03-06 16:36 2015-03-02 Martens Juergen Officer - Corporate VP and COO SELL $6.54 121,333 $793,809 69,202 -63.7%
2015-02-24 05:45 2015-02-19 Thomson David Officer - VP & General Counsel SELL $7.19 68,662 $493,975 141,221 -32.7%
2015-02-13 05:19 2015-02-10 Edstrom Hakan Director, Officer - President & CEO OPT+S $7.75 73,460 $569,315 1,047,824 0.0%
2015-02-09 15:37 2015-02-05 Palumbo Diane Officer - Vice President, Human Resource OPT+S $6.95 149,833 $1,041,339 29,105 0.0%
2015-02-09 15:36 2015-02-05 Thomson David Officer - VP & General Counsel OPT+S $7.00 80,000 $560,000 209,883 0.0%
2015-02-04 01:46 2015-01-30 Edstrom Hakan Director, Officer - President & CEO OPT+S $6.34 73,460 $466,016 1,047,824 0.0%
2015-01-08 01:29 2015-01-05 Palumbo Diane Officer - Vice President, Human Resource OPT+S $5.95 188,999 $1,124,544 29,105 0.0%
2014-12-04 01:29 2014-12-01 Palumbo Diane Officer - Vice President, Human Resource SELL $5.89 183,522 $1,081,734 29,105 -86.3%
2014-12-04 01:28 2014-12-01 Edstrom Hakan Director, Officer - President & COO SELL $5.89 74,668 $440,071 1,047,824 -6.7%
2014-11-27 01:30 2014-11-24 Martens Juergen Officer - Corporate VP OPT+S $6.14 140,000 $860,272 157,083 0.0%
2014-11-27 01:32 2014-11-24 Thomson David Officer - VP & General Counsel SELL $6.14 118,114 $725,775 209,883 -36.0%
2014-11-05 01:20 2014-10-31 Martens Juergen Officer - Corporate VP SELL $6.09 63,800 $388,287 157,083 -28.9%
2014-10-08 01:43 2014-10-03 Martens Juergen Officer - Corporate VP SELL $5.48 63,800 $349,624 220,883 -22.4%
2014-08-30 01:02 2014-08-27 Martens Juergen Officer - Corporate VP OPT+S $7.60 417 $3,169 284,683 0.0%
2014-08-27 01:46 2014-08-22 Martens Juergen Officer - Corporate VP SELL $7.02 22,775 $159,962 284,683 -7.4%
2014-08-20 00:30 2014-08-15 Palumbo Diane Officer - Vice President, Human Resource SELL $7.01 18,726 $131,236 223,078 -7.7%
2014-08-09 01:36 2014-08-07 Thomson David Officer - VP & General Counsel OPT+S $8.16 30,000 $244,752 220,400 0.0%
2014-07-30 00:59 2014-07-28 Martens Juergen Officer - Corporate VP OPT+S $8.55 416 $3,559 190,858 0.0%
2014-07-24 01:01 2014-07-21 Martens Juergen Officer - Corporate VP OPT+S $9.65 26,458 $255,341 190,858 0.0%
2014-07-18 02:30 2014-07-15 Palumbo Diane Officer - Vice President, Human Resource SELL $10.01 17,901 $179,232 241,804 -6.9%
2014-07-18 02:31 2014-07-17 Thomson David Officer - VP & General Counsel OPT+S $9.42 30,000 $282,570 220,400 0.0%
2014-07-04 01:19 2014-07-01 PFEFFER MATTHEW J Officer - Corporate VP and CFO SELL $10.44 20,000 $208,768 126,784 -13.6%
2014-02-27 02:16 2014-02-24 Martens Juergen Officer - Corporate VP OPT+S $6.36 50,000 $317,770 139,450 0.0%
2014-01-29 03:30 2014-01-24 Martens Juergen Officer - Corporate VP OPT+S $5.56 50,000 $278,025 139,450 0.0%
SHOW ENTRIES

How to Interpret $MNKD Trades

Not every insider transaction in MANNKIND CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MNKD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for MNKD

Insider activity data for MANNKIND CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MNKD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.